Stay updated on Clinical Trial: Osi+Sav in EGFRm+/MET+ NSCLC Post-Osi
Sign up to get notified when there's something new on the Clinical Trial: Osi+Sav in EGFRm+/MET+ NSCLC Post-Osi page.

Latest updates to the Clinical Trial: Osi+Sav in EGFRm+/MET+ NSCLC Post-Osi page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedA notice about NIH’s terminology transition was added, and the site revision changed from v3.7.1 to v3.7.2. The study record page still displays a 403 error.SummaryDifference1%

- Check32 days agoChange DetectedThe ClinicalTrials.gov footer revision indicator changed from v3.7.0 to v3.7.1 while the study page remained an error page.SummaryDifference0.2%

- Check45 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study details with a forbidden message. This prevents viewing the trial record and related information on the page.SummaryDifference19%

- Check52 days agoChange DetectedThe page's revision tag was updated from v3.6.6 to v3.7.0, indicating a newer version of the page documentation or interface.SummaryDifference0.0%

- Check66 days agoChange DetectedThe page now shows a new revision tag, v3.6.6, replacing the previous v3.6.5. This indicates a minor platform or CMS update and does not alter the study information.SummaryDifference0.0%

- Check73 days agoChange DetectedA new line under Other Study ID Numbers adds a funding note for 2018.SummaryDifference0.0%

Stay in the know with updates to Clinical Trial: Osi+Sav in EGFRm+/MET+ NSCLC Post-Osi
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Osi+Sav in EGFRm+/MET+ NSCLC Post-Osi page.